Literature DB >> 26402343

Clinical and course characteristics of depression and all-cause mortality: A prospective population-based study.

Aurélie M Lasserre1, Helena Marti-Soler2, Marie-Pierre F Strippoli3, Julien Vaucher4, Jennifer Glaus3, Caroline L Vandeleur3, Enrique Castelao3, Pedro Marques-Vidal2, Gérard Waeber4, Peter Vollenweider4, Martin Preisig3.   

Abstract

BACKGROUND: Given the large heterogeneity of depressive disorders (DD), studying depression characteristics according to clinical manifestations and course is a more promising approach than studying depression as a whole. The purpose of this study was to determine the association between clinical and course characteristics of DD and incident all-cause mortality.
METHODS: CoLaus|PsyCoLaus is a prospective cohort study (mean follow-up duration=5.2 years) including 35-66 year-old randomly selected residents of an urban area in Switzerland. A total of 3668 subjects (mean age 50.9 years, 53.0% women) underwent physical and psychiatric baseline evaluations and had a known vital status at follow-up (98.8% of the baseline sample). Clinical (diagnostic severity, atypical features) and course characteristics (recency, recurrence, duration, onset) of DD according to the DSM-5 were elicited using a semi-structured interview.
RESULTS: Compared to participants who had never experienced DD, participants with current but not remitted DD were more than three times as likely to die (Hazard Ratio: 3.2, 95% CI: 1.1-10.0) after adjustment for socio-demographic and lifestyle characteristics, comorbid anxiety disorders, antidepressant use, and cardiovascular risk factors and diseases. There was no evidence for associations between other depression characteristics and all-cause mortality. LIMITATIONS: The small proportion of deceased subjects impeded statistical analyses of cause-specific mortality.
CONCLUSIONS: A current but not remitted DD is a strong predictor of all-cause mortality, independently of cardiovascular or lifestyle factors, which suggests that the effect of depression on mortality diminishes after remission and further emphasizes the need to adequately treat current depressive episodes.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  All-cause mortality; Cardiovascular risk factors; Current depression; Depressive disorders; Lifestyle; Population-based study; Remission

Mesh:

Year:  2015        PMID: 26402343     DOI: 10.1016/j.jad.2015.09.010

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

1.  The Impact of Depressive Disorder Symptoms and Subtypes on 6-Year Incidence of Somatic Diseases.

Authors:  Roxanne Gaspersz; Femke Lamers; Aartjan T F Beekman; Albert M van Hemert; Robert A Schoevers; Brenda W J H Penninx
Journal:  Psychother Psychosom       Date:  2018-08-16       Impact factor: 17.659

2.  The Ethics of Clinical Trials Research in Severe Mood Disorders.

Authors:  Allison C Nugent; Franklin G Miller; Ioline D Henter; Carlos A Zarate
Journal:  Bioethics       Date:  2017-05-15       Impact factor: 1.898

3.  Observational study of the differential impact of time-varying depressive symptoms on all-cause and cause-specific mortality by health status in community-dwelling adults: the REGARDS study.

Authors:  Nathalie Moise; Yulia Khodneva; Deanna Pereira Jannat-Khah; Joshua Richman; Karina W Davidson; Ian M Kronish; Jonathan Shaffer; Monika M Safford
Journal:  BMJ Open       Date:  2018-01-05       Impact factor: 2.692

4.  Effects of escitalopram and paroxetine on mTORC1 signaling in the rat hippocampus under chronic restraint stress.

Authors:  Mi Kyoung Seo; Cheol Min Choi; Roger S McIntyre; Hye Yeon Cho; Chan Hong Lee; Rodrigo B Mansur; Yena Lee; Jae-Hon Lee; Young Hoon Kim; Sung Woo Park; Jung Goo Lee
Journal:  BMC Neurosci       Date:  2017-04-26       Impact factor: 3.288

5.  Psychometric evaluation of a screening question for persistent depressive disorder.

Authors:  Elisa Brinkmann; Sarah Glanert; Michael Hüppe; Ana Sofia Moncada Garay; Sophie Tschepe; Ulrich Schweiger; Jan Philipp Klein
Journal:  BMC Psychiatry       Date:  2019-04-23       Impact factor: 3.630

6.  Estimating the risk of suicide associated with mental disorders: A systematic review and meta-regression analysis.

Authors:  Modhurima Moitra; Damian Santomauro; Louisa Degenhardt; Pamela Y Collins; Harvey Whiteford; Theo Vos; Alize Ferrari
Journal:  J Psychiatr Res       Date:  2021-03-02       Impact factor: 4.791

7.  Dietary Patterns are Differentially Associated with Atypical and Melancholic Subtypes of Depression.

Authors:  Aurélie M Lasserre; Marie-Pierre F Strippoli; Pedro Marques-Vidal; Lana J Williams; Felice N Jacka; Caroline L Vandeleur; Peter Vollenweider; Martin Preisig
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

8.  Analyses of Antioxidative Properties of Selected Cyclitols and Their Mixtures with Flavanones and Glutathione.

Authors:  Joanna Płonka; Joanna Szablińska-Piernik; Bogusław Buszewski; Irena Baranowska; Lesław B Lahuta
Journal:  Molecules       Date:  2021-12-28       Impact factor: 4.411

9.  Combined influence of depressive symptoms and systemic inflammation on all-cause and cardiovascular mortality: evidence for differential effects by gender in the English Longitudinal Study of Ageing.

Authors:  Samantha Lawes; Panayotes Demakakos; Andrew Steptoe; Glyn Lewis; Livia A Carvalho
Journal:  Psychol Med       Date:  2018-09-17       Impact factor: 7.723

10.  Study of efficacy and safety of Jiaotai pill in the treatment of depression.

Authors:  Zhihuan Zhou; Shufei Fu; Yijia Liu; Yuhan Wang; Huaien Bu; Yan Mei; Yi Tong; Chunquan Yu
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.